Cost savings outweigh increased pill intake for most patients.
While defective forms of HIV were thought to be harmless, studies show they're tricking our immune systems into thinking we have more HIV in our bodies than is the case.
It might sound too good to be true, but a new generation of cells are now able to block HIV altogether.
An antibody typically used to treat inflammatory bowel disease ended up keeping HIV in check.
A man who received a bone marrow transplant had a subsequent remission of HIV-related health issues and has now been found to be undetectable as well.
Are we in for a new kind of PrEP? Researchers found that a certain antibiotic showed a 70 percent drop in common STIs.
If approved, ibalizumab will be the first antiretroviral treatment with a new mechanism of action to be approved in nearly a decade.